GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bioventix BVXP.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

1,925.00p

-1.28%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Bioventix — daily BVXP

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Bioventix on TradingView ↗
Market value
£100.5m
Last close × shares
Volume
5.7k
Shares, 9 Nov 2026
Price to earnings
1323.3
Dividend yield
0.08%

About Bioventix

Its shares trade on LSE under the ticker BVXP.L. It has been listed since 29 April 2014. In the fiscal year to 30 June 2026, it reported revenue of £13.0m and net income of £7.6m. At that date it held total assets of £12.8m and shareholders' equity of £11.4m.

Bioventix Plc engages in the development and supply of antibodies. The company is headquartered in Farnham, Surrey. The company went IPO on 2014-04-29. The principal activity of the Company is the development and supply of antibodies. The firm specializes in the development of sheep monoclonal antibodies (SMAs) for use in immunodiagnostics focusing on the areas of clinical diagnostics and drugs of abuse testing. The firm's non-vitamin D business consists of antibodies, NT proBNP (heart failure), testosterone, Free Triiodothyronine (FT3) (thyroid hormone), estradiol, and various drugs, such as tetrahydrocannabinol (THC)/cannabis, and progesterone. The firm offers products for indications, such as thyroid, fertility, oncology, cardiac, vitamin D, drug of abuse, infectious disease and miscellaneous. Its sheep hybridoma technology produces cell lines that secrete SMAs. The firm offers a panel of SMAs to 25-OH D and has various 25-OH D2 and 25-OH D3 specific antibodies. The company sells its products through direct sales and through distributors.

Figures and description from our data supplier, not checked against the company's own report.

More about Bioventix →

Latest on Bioventix

Our reporting

We have not reported on Bioventix yet.

Next results

29 Mar 2027

Due on 29 Mar 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Bioventix's ticker?

Bioventix trades as BVXP.L on LSE, under ISIN GB00B4QVDF07.

What was Bioventix's last closing price?

1,925.00p on 9 Nov 2026. The figure is in GBp and is never converted.

When does Bioventix next report results?

Results are expected on 29 Mar 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.